{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:56Z","timestamp":1787181896978,"version":"build-2736575974"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119822","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:00:25Z","timestamp":1785751225000},"page":"119822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives"],"prefix":"10.1016","volume":"202","author":[{"given":"Marissa","family":"El Hajje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luiz","family":"Coelho-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-8109","authenticated-orcid":false,"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-2531","authenticated-orcid":false,"given":"Gustavo Henrique Goulart","family":"Trossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119822_bib1","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.240209","article-title":"The post-translational modification O-GlcNAc is a sensor and regulator of metabolism","volume":"14","author":"Morales","year":"2024","journal-title":"Open. Biol."},{"key":"10.1016\/j.biopha.2026.119822_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature09638","article-title":"Structure of human O-GlcNAc transferase and its complex with a peptide substrate","volume":"469","author":"Lazarus","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119822_bib3","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1016\/j.jmb.2016.05.028","article-title":"O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling","volume":"428","author":"Ferrer","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119822_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105344","article-title":"On a sugar high: Role of O-GlcNAcylation in cancer","volume":"299","author":"Le Minh","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-022-00544-y","article-title":"O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy","volume":"28","author":"Lu","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.biopha.2026.119822_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1158\/1541-7786.MCR-20-0926","article-title":"O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?","volume":"19","author":"Itkonen","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119822_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exphem.2021.07.003","article-title":"O-GlcNAcylation: Implications in normal and malignant hematopoiesis","volume":"102","author":"Nakajima","year":"2021","journal-title":"Exp. Hematol. 101"},{"key":"10.1016\/j.biopha.2026.119822_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772304","article-title":"O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers","volume":"12","author":"Spaner","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119822_bib9","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1073\/pnas.100471497","article-title":"The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny","volume":"97","author":"Shafi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00335-001-2108-9","article-title":"Human O-GlcNAc transferase (OGT): genomic structure, analysis of splice variants, fine mapping in Xq13.1","volume":"13","author":"Nolte","year":"2002","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.biopha.2026.119822_bib11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nsmb833","article-title":"The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha","volume":"11","author":"J\u00ednek","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119822_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26796-6","article-title":"Cryo-EM structure provides insights into the dimer arrangement of the O-linked \u03b2-N-acetylglucosamine transferase OGT","volume":"12","author":"Meek","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119822_bib13","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.1038\/s41467-023-42427-8","article-title":"Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex","volume":"14","author":"Lu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119822_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1021\/acs.biochem.0c00981","article-title":"Protein Substrates Engage the Lumen of O-GlcNAc Transferase\u2019s Tetratricopeptide Repeat Domain in Different Ways","volume":"60","author":"Joiner","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119822_bib15","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1007\/s00216-021-03731-8","article-title":"Truncation of the TPR domain of OGT alters substrate and glycosite selection","volume":"413","author":"Ramirez","year":"2021","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2401729121","article-title":"Dissecting OGT\u2019s TPR domain to identify determinants of cellular function","volume":"121","author":"Potter","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib17","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/jacs.7b13546","article-title":"O-GlcNAc transferase recognizes protein substrates using an asparagine ladder in the TPR superhelix","volume":"140","author":"Levine","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119822_bib18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1126\/science.1243990","article-title":"HCF-1 is cleaved in the active site of O-GlcNAc transferase","volume":"342","author":"Lazarus","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119822_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cell.2010.12.030","article-title":"O-GlcNAc transferase catalyzes site-specific proteolysis of HCF-1","volume":"144","author":"Capotosti","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119822_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016778118","article-title":"Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase","volume":"118","author":"Levine","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib21","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.1074\/jbc.M113.523068","article-title":"Cross-talk between Two Essential Nutrient-sensitive Enzymes: O-GlcNAc TRANSFERASE (OGT) AND AMP-ACTIVATED PROTEIN KINASE (AMPK)","volume":"289","author":"Bullen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib22","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1074\/jbc.M109.077818","article-title":"Regulation of insulin receptor substrate 1 (IRS-1)\/AKT kinase-mediated insulin signaling by O-linked \u03b2-N-acetylglucosamine in 3T3-L1 adipocytes","volume":"285","author":"Whelan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib23","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1093\/nar\/gkaa263","article-title":"O-GlcNAc regulates gene expression by controlling detained intron splicing","volume":"48","author":"Tan","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2026.119822_bib24","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1146\/annurev-biochem-060608-102511","article-title":"Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease","volume":"80","author":"Hart","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.biopha.2026.119822_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cells7060053","article-title":"The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring","volume":"7","author":"Chiaradonna","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119822_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/genes14040933","article-title":"The Hexosamine Biosynthesis Pathway: Regulation and Function","volume":"14","author":"Paneque","year":"2023","journal-title":"Genes. (Basel)"},{"key":"10.1016\/j.biopha.2026.119822_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02687-3","article-title":"Exploring the metabolic signaling network of GFPT in cancer","volume":"11","author":"Sampson","year":"2025","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.biopha.2026.119822_bib28","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/0008-5472.CAN-13-0549","article-title":"O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells","volume":"73","author":"Itkonen","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119822_bib29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119822_bib30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1126\/science.1222278","article-title":"Phosphofructokinase 1 glycosylation regulates cell growth and metabolism","volume":"337","author":"Yi","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119822_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41388-019-0975-3","article-title":"O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth","volume":"39","author":"Singh","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119822_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13601-8","article-title":"O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth","volume":"11","author":"Nie","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119822_bib33","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1535-7163.MCT-18-0426","article-title":"Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death","volume":"17","author":"Asthana","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119822_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1327405","article-title":"Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells","volume":"15","author":"Schauner","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119822_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48991-8","article-title":"Blocked O-GlcNAc cycling disrupts mouse hematopoeitic stem cell maintenance and early T cell development","volume":"9","author":"Abramowitz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119822_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108579","article-title":"OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy","volume":"34","author":"Murakami","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.biopha.2026.119822_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107349","article-title":"O-GlcNAcylation and immune cell signaling: A review of known and a preview of unknown","volume":"300","author":"Ramakrishnan","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01677-z","article-title":"O-GlcNAcylation is required for B cell homeostasis and antibody responses","volume":"8","author":"Wu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119822_bib39","article-title":"O-GlcNAc glycosylation orchestrates fate decision and niche function of bone marrow stromal progenitors","volume":"12","author":"Zhang","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2026.119822_bib40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/stmcls\/sxac068","article-title":"Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3\/5 Signaling","volume":"40","author":"Luanpitpong","year":"2022","journal-title":"Stem Cells"},{"key":"10.1016\/j.biopha.2026.119822_bib41","article-title":"O-Glcnacylation Is Essential for Erythropoiesis","author":"Parker","year":"2019","journal-title":"Blood Am. Soc. Hematol."},{"key":"10.1016\/j.biopha.2026.119822_bib42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.RA118.005993","article-title":"O-GlcNAc homeostasis contributes to cell fate decisions during hematopoiesis","volume":"294","author":"Zhang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib43","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/leu.2017.4","article-title":"O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies","volume":"31","author":"Freund","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2026.119822_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113154","article-title":"O-GlcNAc Transferase Inhibitor Synergistically Enhances Doxorubicin-Induced Apoptosis in HepG2 Cells","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2026.119822_bib45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41375-018-0083-3","article-title":"A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies","volume":"32","author":"Inoue","year":"2018","journal-title":"Leukemia"},{"issue":"17 (","key":"10.1016\/j.biopha.2026.119822_bib46","article-title":"Can O-GIcNAc Transferase (OGT) Complex Be Used as a Target for the Treatment of Hematological Malignancies","volume":"17","author":"Zhuang","year":"2024","journal-title":"Pharmaceuticals 2024"},{"key":"10.1016\/j.biopha.2026.119822_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-025-02058-6","article-title":"O-GlcNAcylated FTO promotes m6A modification of SOX4 to enhance MDS\/AML cell proliferation","volume":"23","author":"Gou","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.biopha.2026.119822_bib48","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/leu.2010.152","article-title":"Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia","volume":"24","author":"Shi","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2026.119822_bib49","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119822_bib50","doi-asserted-by":"crossref","first-page":"80599","DOI":"10.18632\/oncotarget.12413","article-title":"Targeting the hexosamine biosynthetic pathway and Olinked Nacetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large Bcell lymphoma","volume":"7","author":"Pham","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119822_bib51","doi-asserted-by":"crossref","first-page":"13732","DOI":"10.1073\/pnas.1704145115","article-title":"O- GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib52","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/1535-7163.MCT-17-0390","article-title":"Inhibition of O-GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid","volume":"17","author":"Luanpitpong","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119822_bib53","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/s41401-025-01500-2","article-title":"Inhibition of CDC27 O-GlcNAcylation coordinates the antitumor efficacy in multiple myeloma through the autophagy-lysosome pathway","volume":"46","author":"Wu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2026.119822_bib54","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-021-01876-z","article-title":"O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination","volume":"40","author":"Samart","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119822_bib55","doi-asserted-by":"crossref","first-page":"19915","DOI":"10.1073\/pnas.1009023107","article-title":"Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code","volume":"107","author":"Sakabe","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature10656","article-title":"GlcNAcylation of histone H2B facilitates its monoubiquitination","volume":"480","author":"Fujiki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119822_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13072-023-00523-5","article-title":"O-GlcNAcylation: the sweet side of epigenetics","volume":"16","author":"Dupas","year":"2023","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.biopha.2026.119822_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature11742","article-title":"TET2 promotes histone O-GlcNAcylation during gene transcription","volume":"493","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119822_bib59","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/emboj.2012.357","article-title":"TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1\/COMPASS","volume":"32","author":"Deplus","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2026.119822_bib60","doi-asserted-by":"crossref","first-page":"20776","DOI":"10.1074\/jbc.M113.460386","article-title":"Ten-eleven translocation 1 (Tet1) is regulated by o-linked n-acetylglucosamine transferase (ogt) for target gene repression in mouse embryonic stem cells","volume":"288","author":"Shi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib61","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1073\/pnas.1323226111","article-title":"O-GlcNAcylation regulates EZH2 protein stability and function","volume":"111","author":"Chu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib62","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.270.32.18961","article-title":"c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas","volume":"270","author":"Chou","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119822_bib63","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ncb1470","article-title":"Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability","volume":"8","author":"Yang","year":"2006","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119822_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10886-x","article-title":"Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma","volume":"7","author":"Luanpitpong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119822_bib65","doi-asserted-by":"crossref","first-page":"16888","DOI":"10.1073\/pnas.1208468109","article-title":"Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-\u03baB acetylation and transcription","volume":"109","author":"Allison","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2026.119822_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1242\/jcs.053678","article-title":"The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways","volume":"123","author":"Zeidan","year":"2010","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2026.119822_bib67","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1111\/febs.14491","article-title":"Crosstalk between phosphorylation and O-GlcNAcylation: friend or foe","volume":"285","author":"van der Laarse","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2026.119822_bib68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2012.05.036","article-title":"Systematic functional prioritization of protein posttranslational modifications","volume":"150","author":"Beltrao","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2026.119822_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216796120","article-title":"O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation","volume":"120","author":"Zhu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib70","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/2326-6066.CIR-19-0904","article-title":"Hyperglycemia Enhances Cancer Immune Evasion by Inducing Alternative Macrophage Polarization through Increased O-GlcNAcylation","volume":"8","author":"Mantuano","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2026.119822_bib71","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/acschembio.5b00004","article-title":"A small molecule that inhibits OGT activity in cells","volume":"10","author":"Ortiz-Meoz","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119822_bib72","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1021\/jacs.8b07328","article-title":"Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors","volume":"140","author":"Martin","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119822_bib73","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/BJ20131272","article-title":"Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors","volume":"457","author":"Borodkin","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2026.119822_bib74","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3390\/molecules27061996","article-title":"Discovery of a New Drug-Like Series of OGT Inhibitors by Virtual Screening","volume":"27","author":"Loi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119822_bib75","doi-asserted-by":"crossref","first-page":"26320","DOI":"10.1021\/jacs.4c08656","article-title":"Identification of a Polypeptide Inhibitor of O-GlcNAc Transferase with Picomolar Affinity","volume":"146","author":"Hammel","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2026.119822_bib76","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1021\/acs.biochem.9b00560","article-title":"Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress","volume":"59","author":"Walter","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2026.119822_bib77","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1158\/1535-7163.MCT-17-1148","article-title":"We\u2019re Not \u201cDON\u201d Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine","volume":"17","author":"Lemberg","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2026.119822_bib78","doi-asserted-by":"crossref","first-page":"25717","DOI":"10.1039\/D5RA02801A","article-title":"OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells","volume":"15","author":"Bricelj","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2026.119822_bib79","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409501121","article-title":"Ultradeep O-GlcNAc proteomics reveals widespread O-GlcNAcylation on tyrosine residues of proteins","volume":"121","author":"Hou","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.biopha.2026.119822_bib80","article-title":"O-GlcNAcylation reduces proteome solubility and regulates the formation of biomolecular condensates in human cells","volume":"16","author":"Xu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119822_bib81","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41556-023-01258-x","article-title":"O-GlcNAcylation determines the translational regulation and phase separation of YTHDF proteins","volume":"25","author":"Chen","year":"2023","journal-title":"Nat. Cell. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:50:25Z","timestamp":1787179825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":81,"alternative-id":["S0753332226008589"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119822","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119822","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119822"}}